Dublin, Jan. 18, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/5rzpcl/the_global) has announced the addition of the "The Global Glucose Monitoring Market" report to their offering.
Diabetes is a leading cause of death and disability in the worldwide. It increases the risk for heart disease, end-stage renal disease, blindness, amputation, andcomplications of pregnancy and is ranked as the sixth leading cause of death. Disease prevalence is driving sales of monitoring equipment. The glucose monitoring device and diabetes management market is focused on utilizing advancements recently introduced to provide easier-to-use products and more accurate glucose monitoring.
The Global Glucose Monitoring Market provides market estimates and forecasts for this important test category. As part of its coverage, the report breaks out the revenues earned by the glucose monitoring industry into appropriate segments so that businesses can assess the right market opportunity for the area they compete in.
There are many issues facing this industry. Some issues are helping to propel the market; while other issues are retarding growth forward. Issues and trends driving the market for glucose monitoring devices and diabetes management include: New innovations, Reimbursement challenges, Recalls, Aging of the population, Increasing life expectancy, Healthcare spending trends, Advances in sensors, Health insurance portability, Cost cutting, Healthcare efficiency, Capacity challenges, Growing acceptance of mobile technologies and other factors. These are discussed at length in the report, as are their role in market growth.
Although there are many participants in the market, a handful of companies continue to make a significant impact on the glucose monitoring devices and diabetes management market.
A select few are discussed here, including:
- Abbott Laboratories
- AgaMatrix Arkray, Inc
- Bayer Diabetes Bionime Corporation
- DexCom, Inc.
- Echo Therapeutics
- Entra Health Systems LLC
- Fora Care Inc
- Genesis Health Technologies
- GlySure Limited
- Insulet
- Johnson & Johnson
- Medtronic
- Nipro Diagnostics, Inc
- Nova Diabetes Care, Inc.
- Oak Tree International Holdings, Inc
- Prodigy Diabetes Care, LLC
- Roche U.S. Diagnostics, Inc.
Key Topics Covered:
- Executive Summary
- Introduction
- Traditional Glucose Monitoring Devices And Diabetes Management Market
- Continuous Glucose Monitoring And Sensor Market
- Issues And Trends
- Global Glucose Monitoring Devices And Diabetes Management Market And Competitor Analysis
- Market Analysis By Region
- Corporate Profiles
For more information visit http://www.researchandmarkets.com/research/5rzpcl/the_global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Glucose Testing, Diabetes Devices


AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



